Mouse Anti-Capsaicin monoclonal antibody, clone CPS

In addition to adding flavor and excitement to human meals, capsaicin, the main active ingredient in chili peppers, has significant scientific and therapeutic advantages. The usage of capsaicin to reduce pain is among its most obvious effects. Capsaicin causes analgesia via attaching to the TRPV1 receptor, which detects temperature and pain at nerve terminals. Capsaicin desensitizes nerve fibers by repeatedly activating this receptor, reducing the transmission of painful impulses. Numerous clinical disorders, including neuropathic pain, have been successfully treated using topical capsaicin formulations. Postherpetic neuralgia, a frequent type of chronic pain, can cause continuous, intense pain as a result of nerve injury. Capsaicin decreases pain by repeatedly stimulating pain receptors and lowering the sensitivity of neurons to pain signals. Because of this effect, capsaicin can be used to treat chronic pain conditions including rheumatoid arthritis and osteoarthritis. Additionally, capsaicin patches have shown remarkable effectiveness in reducing muscle soreness following athletic injuries, which has led to their growing application in sports rehabilitation. Capsaicin has been shown to have anti-inflammatory properties in addition to its analgesic properties in studies of a variety of illnesses. By stopping the release of inflammatory factors, capsaicin lowers inflammation. Capsaicin has been shown in rheumatoid arthritis research to inhibit inflammatory signaling pathways, such as the NF-κB, which reduces the production of inflammatory chemicals including prostaglandins and leukotrienes. Additionally, studies have demonstrated that capsaicin has some inhibitory effects on gastrointestinal inflammation, which may reduce the incidence of ulcers and gastritis. Capsaicin intake needs to be carefully watched, though, since too much of it might irritate the gastrointestinal tract and even exacerbate inflammation. Therefore, balancing side effects and efficacy through dosage adjustments remains a top research focus in clinical trials and drug development.

Figure 1. Chemical structure of capsaicin and capsaicin esters (Source: Zhang W, et al., 2024)

Capsaicin's effects on cardiovascular health have received significant study. It has been demonstrated to reduce blood pressure by activating TRPV1 receptors, which stimulates nitric oxide release, resulting in vasodilation and better blood flow. Several animal studies have proven capsaicin's ability to prevent atherosclerosis. Capsaicin lowers blood cholesterol and triglyceride levels, which helps minimize lipid deposition in artery walls, lessening the risk of arteriosclerosis. Furthermore, capsaicin has anti-thrombotic characteristics by suppressing platelet aggregation, which lowers the risk of thromboembolic cardiovascular events such as heart disease and stroke. Although most research are now limited to experimental animals, capsaicin shows promise as a cardiovascular protectant for future medication development. Capsaicin has also been shown to have substantial metabolic regulatory properties. Numerous studies have shown that capsaicin can assist manage body weight by increasing energy expenditure. This impact is mostly due to the thermogenic effect caused by capsaicin. Capsaicin activates TRPV1 receptors, which causes brown adipose tissue to produce greater heat, boosting energy expenditure. This thermogenic impact is most noticeable during activity, greatly increasing the rate of fat burning. Furthermore, capsaicin has appetite suppressant characteristics; studies have shown that it can increase feelings of fullness while decreasing overall food consumption, making it potentially useful in weight loss strategies for obese people.

Scientists have recently become interested in the potential applications of capsaicin in cancer research. Capsaicin has many anti-cancer mechanisms that can effectively limit the growth and spread of different types of cancer cells. To begin, capsaicin has the ability to trigger apoptosis in cancer cells, specifically via activating apoptotic pathways involving caspase family members, resulting in programmed cell death. Additionally, capsaicin can decrease cancer cell proliferation by regulating the expression of cell cycle-related proteins. Capsaicin has been shown in numerous experimental experiments to greatly limit the growth of cancer cells in breast cancer, prostate cancer, colon cancer, and other conditions. Capsaicin can also prevent tumor angiogenesis by inhibiting angiogenic factors such as VEGF, lowering tumors' reliance on blood supply and limiting their spread. Despite these findings, which suggest capsaicin's promise in cancer therapy, the majority of research is still being conducted in cell and animal models. Additional clinical trials are needed to determine the effects of capsaicin on cancer in humans, as well as its safety and effective dosage. In conclusion, capsaicin has a high biological significance for scientific research and a wide range of medical applications. Capsaicin's analgesic, anti-inflammatory, metabolic regulating, anti-cancer, and cardiovascular protective properties indicate that it may play an essential role in the treatment and prevention of a variety of disorders. As research advances, capsaicin's clinical applications are projected to grow even further. However, additional research is needed into capsaicin's pharmacological mechanisms, dose dependence, and long-term safety, particularly large-scale clinical trials to evaluate its efficacy and adverse effects. In the future, capsaicin is likely to play an increasingly important role in science and medicine, offering new treatment strategies for various diseases.

Anti-capsaicin antibody
Capsaicin monoclonal antibody
CPS antibody